Strategies for Long-Term Follow-Up of Gene Therapies
Leveraging decentralized approaches and real world data
Cell and gene therapies have the potential to transform the lives of patients with life-threatening illnesses. While there is great promise, bringing these new therapies to market is far from simple. One of the biggest challenges is the required long-term follow-up monitoring for up to 15 years.
Download the insight brief Long-term follow-up for gene therapies to learn about tailored, patient-centric approaches and more:
How to determine when long-term follow-up (LTFU) is needed in clinical trial and approved product settings
Clinical considerations in designing LTFU studies for gene therapies
Data collection methods to reduce site and patient burden
Flexible decentralized approaches to LTFU studies that can reduce risk and improve the patient experience
